• 4698 Citations
  • 38 h-Index
1980 …2019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 1980 2019

Filter
Review article
2019
2 Citations (Scopus)

Selective serotonin reuptake inhibitor use and risk of gastrointestinal and intracranial bleeding

Yuet, W. C., Derasari, D., Sivoravong, J., Mason, D. & Jann, M., Feb 2019, In : Journal of the American Osteopathic Association. 119, 2, p. 102-111 10 p.

Research output: Contribution to journalReview article

Serotonin Uptake Inhibitors
Hemorrhage
clopidogrel
Gastrointestinal Tract
Osteopathic Physicians

The Evolving Role of Pharmacists in Transgender Health Care

Redfern, J. S. & Jann, M. W., 11 Apr 2019, In : Transgender Health. 4, 1, p. 118-130 13 p.

Research output: Contribution to journalReview article

Open Access
Transgender Persons
pharmacist
Pharmacists
health care
Delivery of Health Care
2018
10 Citations (Scopus)

Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents

Jann, M. W. & Penzak, S. R., 1 Mar 2018, In : CNS Drugs. 32, 3, p. 241-257 17 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Injections
olanzapine
Risperidone
Patient Education
2014
33 Citations (Scopus)
Bipolar Disorder
Therapeutics
Bipolar disorder
Antipsychotic Agents
Second-Generation Antidepressive Agents
2013
44 Citations (Scopus)

Clinically significant drug interactions with atypical antipsychotics

Kennedy, W. K., Jann, M. W. & Kutscher, E. C., 1 Dec 2013, In : CNS Drugs. 27, 12, p. 1021-1048 28 p.

Research output: Contribution to journalReview article

Drug Interactions
Antipsychotic Agents
Pharmaceutical Preparations
Anticonvulsants
Pharmacokinetics
2011
7 Citations (Scopus)

Advanced strategies for treatment of Parkinson's disease: the role of early treatment.

Jann, M. W., 1 Jan 2011, In : The American journal of managed care. 17 Suppl 12

Research output: Contribution to journalReview article

Parkinson Disease
Levodopa
Monoamine Oxidase Inhibitors
Activities of Daily Living
Therapeutics
2007
124 Citations (Scopus)

Antidepressant agents for the treatment of chronic pain and depression

Jann, M. W. & Slade, J. H., 1 Nov 2007, In : Pharmacotherapy. 27, 11, p. 1571-1587 17 p.

Research output: Contribution to journalReview article

Chronic Pain
Antidepressive Agents
Depression
Pain
Therapeutics
2004
38 Citations (Scopus)

Implications for atypical antipsychotics in the treatment of schizophrenia: Neurocognition effects and a neuroprotective hypothesis

Jann, M. W., 1 Dec 2004, In : Pharmacotherapy. 24, 12 I, p. 1759-1783 25 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Schizophrenia
Prefrontal Cortex
Catechol O-Methyltransferase
Dopamine
2002
253 Citations (Scopus)

Clinical pharmacokinetics and pharmacodynamics of cholinesterase inhibitors

Jann, M. W., Shirley, K. L. & Small, G. W., 1 Jan 2002, In : Clinical Pharmacokinetics. 41, 10, p. 719-739 21 p.

Research output: Contribution to journalReview article

Cholinesterase Inhibitors
Rivastigmine
Pharmacokinetics
Galantamine
Tacrine
2001
172 Citations (Scopus)

Smoking in patients receiving psychotrophic medications: A pharmacokinetic perspective

Desai, H. D., Seabolt, J. & Jann, M. W., 1 Jan 2001, In : CNS Drugs. 15, 6, p. 469-494 26 p.

Research output: Contribution to journalReview article

Pharmacokinetics
Smoking
Smoke
Tobacco Products
Bupropion
2000
29 Citations (Scopus)

Cholinesterase inhibitors for the treatment of Alzheimer's disease in the elderly

VanDenBerg, C. M., Kazmi, Y. & Jann, M. W., 1 Jan 2000, In : Drugs and Aging. 16, 2, p. 123-138 16 p.

Research output: Contribution to journalReview article

Cholinesterase Inhibitors
Alzheimer Disease
Therapeutics
Drug Interactions
Population
68 Citations (Scopus)

Major depression in women: a review of the literature.

Desai, H. D. & Jann, M. W., 1 Jan 2000, In : Journal of the American Pharmaceutical Association (Washington,D.C. : 1996). 40, 4, p. 525-537 13 p.

Research output: Contribution to journalReview article

Depression
Pharmacists
Electroconvulsive Therapy
Symptom Assessment
Sex Offenses
148 Citations (Scopus)

Rivastigmine, a new-generation cholinesterase inhibitor for the treatment of Alzheimer's disease

Jann, M. W., 1 Jan 2000, In : Pharmacotherapy. 20, 1 I, p. 1-12 12 p.

Research output: Contribution to journalReview article

Rivastigmine
Cholinesterase Inhibitors
Alzheimer Disease
Therapeutics
Tacrine
1998
21 Citations (Scopus)

Drug interactions with antipsychotic agents incidence and therapeutic implications

ZumBrunnen, T. L. & Jann, M. W., 2 Jun 1998, In : CNS Drugs. 9, 5, p. 381-401 21 p.

Research output: Contribution to journalReview article

Drug Interactions
Antipsychotic Agents
Incidence
Cytochrome P-450 Enzyme System
Therapeutics
32 Citations (Scopus)

Preclinical pharmacology of metrifonate

Jann, M. W., 1 Mar 1998, In : Pharmacotherapy. 18, 2 II SUPPL.

Research output: Contribution to journalReview article

Trichlorfon
Dichlorvos
Cholinesterase Inhibitors
Pharmacology
Acetylcholine
1997
23 Citations (Scopus)

Venlafaxine and nefazodone, two pharmacologically distinct antidepressants

Augustin, B. G., Cold, J. A. & Jann, M. W., 1 May 1997, In : Pharmacotherapy. 17, 3, p. 511-530 20 p.

Research output: Contribution to journalReview article

Antidepressive Agents
Serotonin Uptake Inhibitors
Serotonin
Phenethylamines
United States Food and Drug Administration
1995
24 Citations (Scopus)

Emergency Treatment of Psychotic Symptoms: Pharmacokinetic Considerations for Antipsychotic Drugs

Milton, G. V. & Jann, M. W., 1 Jan 1995, In : Clinical Pharmacokinetics. 28, 6, p. 494-504 11 p.

Research output: Contribution to journalReview article

Emergency Treatment
Antipsychotic Agents
Pharmacokinetics
Emergencies
Drug Interactions
1993
202 Citations (Scopus)

Pharmacokinetics and Pharmacodynamics of Clozapine

Jann, M. W., Griley, S. R., Gray, E. C. & Chang, W. H., 1 Jan 1993, In : Clinical Pharmacokinetics. 24, 2, p. 161-176 16 p.

Research output: Contribution to journalReview article

Clozapine
Pharmacokinetics
Schizophrenia
Agranulocytosis
Molecular Mechanisms of Pharmacological Action
1992
193 Citations (Scopus)

Paroxetine, sertraline, and fluvoxamine: New selective serotonin reuptake inhibitors

Grimsley, S. R. & Jann, M. W., 1 Jan 1992, In : Clinical Pharmacy. 11, 11, p. 930-957 28 p.

Research output: Contribution to journalReview article

Fluvoxamine
Sertraline
Paroxetine
Serotonin Uptake Inhibitors
Placebos
11 Citations (Scopus)

Therapeutic frontiers in Alzheimer's disease

Miller, S. W., Mahoney, J. M. & Jann, M. W., 30 Jun 1992, In : Pharmacotherapy. 12, 3, p. 217-231 15 p.

Research output: Contribution to journalReview article

Alzheimer Disease
Cholinergic Neurons
Nerve Growth Factors
Drug Delivery Systems
Geriatrics
1990
6 Citations (Scopus)

Movement disorders and new azapirone anxiolytic drugs

Jann, M. W., Froemming, J. H. & Borison, R. L., 1 Jan 1990, In : Journal of the American Board of Family Practice. 3, 2, p. 111-119 9 p.

Research output: Contribution to journalReview article

Buspirone
Anti-Anxiety Agents
Movement Disorders
Antipsychotic Agents
Pharmaceutical Preparations
1989
109 Citations (Scopus)

Pharmacokinetics of Haloperidol

Froemming, J. S., Lam, Y. W. F., Jann, M. W. & Davis, C. M., Dec 1989, In : Clinical Pharmacokinetics. 17, 6, p. 396-423 28 p.

Research output: Contribution to journalReview article

Haloperidol
Pharmacokinetics
Gas Chromatography
Radioimmunoassay
High Pressure Liquid Chromatography
1988
59 Citations (Scopus)

Buspirone: An Update on a Unique Anxiolytic Agent

Jann, M. W., 1 Jan 1988, In : Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 8, 2, p. 100-116 17 p.

Research output: Contribution to journalReview article

Buspirone
Anti-Anxiety Agents
Sensory Receptor Cells
Benzodiazepines
Half-Life
1987
11 Citations (Scopus)

Treatment of panic and phobic disorders

Jann, M. W. & Kurtz, N. M., 1 Dec 1987, In : Clinical Pharmacy. 6, 12, p. 947-962 16 p.

Research output: Contribution to journalReview article

Phobic Disorders
Panic Disorder
Monoamine Oxidase Inhibitors
Locus Coeruleus
Tricyclic Antidepressive Agents
1985
75 Citations (Scopus)

Clinical Pharmacokinetics of the Depot Antipsychotics

Jann, M. W., Ereshefsky, L. & Saklad, S. R., 1 Jan 1985, In : Clinical Pharmacokinetics. 10, 4, p. 315-333 19 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Decanoates
Pharmacokinetics
Injections
Half-Life
1984
4 Citations (Scopus)

Alternative drug therapies for mania: A literature review

Jann, M. W., Garrelts, J. C., Ereshefsky, L. & Saklad, S. R., 1 Jan 1984, In : Drug Intelligence and Clinical Pharmacy. 18, 7-8, p. 577-589 13 p.

Research output: Contribution to journalReview article

Complementary Therapies
Bipolar Disorder
Drug Therapy
Clorgyline
Carbamazepine
62 Citations (Scopus)

Future of depot neuroleptic therapy: Pharmacokinetic and pharmacodynamic approaches

Ereshefsky, L., Saklad, S. R., Jann, M. W., Davis, C. M., Richards, A. & Seidel, D. R., 2 Aug 1984, In : Journal of Clinical Psychiatry. 45, 5 II, p. 50-59 10 p.

Research output: Contribution to journalReview article

Antipsychotic Agents
Pharmacokinetics
Dosage Forms
Haloperidol
Therapeutics
1980
26 Citations (Scopus)

Drug withdrawal syndromes. A literature review

Hodding, G. C., Jann, M. W. & Ackerman, I. P., 1 Dec 1980, In : Western Journal of Medicine. 133, 5, p. 383-391 9 p.

Research output: Contribution to journalReview article

Substance Withdrawal Syndrome
Psychotropic Drugs
Narcotics
Clonidine
Propranolol